Navigation Links
Results of phase III study on Labopharm's novel antidepressant published in Psychiatry (Edgemont) Journal
Date:5/19/2009

ts with major unipolar depressive disorder (MDD).

The results of primary efficacy end point analyses demonstrated consistent statistical superiority of Labopharm's trazodone formulation over placebo. Moreover, statistically significant improvements were demonstrated on several secondary efficacy end points, including Hamilton Rating Scale for Depression (HAMD-17) responders, Montgomery-Asberg Depression Rating Scale (MADRS) score, and quality of sleep.

The authors emphasize the clinical importance of targeting sleep improvement in patients with MDD, which is reported in more than 90% of cases. Patients receiving Labopharm's trazodone formulation demonstrated significant improvements versus placebo in all three quality of sleep end points, with an improvement by the first week of therapy in "overall quality of sleep" and "awakening during the night".

Agitation is a common symptom of MDD and patients taking antidepressants often experience an exacerbation of this symptom. In the study, those administered Labopharm's trazodone formulation showed no increase in agitation.

The results of the study demonstrate Labopharm's once-daily trazodone may have a early onset of action. The overall antidepressant efficacy of Labopharm's trazodone formulation was accompanied by improvements early in the study, including an early improvement in HAMD-17 scores, which suggest that patients may see clinical benefit within the first 2 weeks of treatment, and a significantly greater number of HAMD-17 responders than placebo by the end of titration.

Adverse events of particular concern in the treatment of MDD are those related to weight gain and sexual dysfunction, as they are among the most prevalent reasons for discontinuation of antidepressant therapy. In the study, there were no significant changes in body weight in either those administered Labopharm's trazodone formulation or those administered placebo and there was a low incidence of sexual dy
'/>"/>

SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. International Isotopes Inc. Announces First Quarter 2009 Financial Results
2. Encision Reports Fourth Quarter and Fiscal Year 2009 Results
3. Uroplasty to Issue Fourth Fiscal Quarter and Full Year Results on June 4, 2009
4. BMP Sunstone Reports First Quarter 2009 Financial Results
5. Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain
6. Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
7. Jiangbo Pharmaceuticals Reports Results for the Third Quarter of its Fiscal Year 2009
8. AdCare Health Systems, Inc. Turns Profitable; Reports 2009 First Quarter Earnings Results
9. Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer
10. Derma Sciences Reports First Quarter 2009 Results
11. NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 23, 2015 VogueQueen is a seasoned ... prices and many designers are thrilled to have it lead ... announces its new collection of prom dresses for the global ... drive the strategic vision and he focuses on continuing the ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota ... it means to “Live Fearless.” , The “Faces ... their stories about how they or someone they know has ... living in the moment. By telling these types of stories ...
(Date:1/22/2015)... Orlando, Florida (PRWEB) January 22, 2015 ... up today at the 2015 PGA Merchandise Show to ... lady and incredible female amateur golfer, Arlene McKitrick. The ... career female amateur golf tournament win. She won her ...
(Date:1/22/2015)... 22, 2015 Autocarinsurancebest.com has released a new ... commercial auto insurance policy . , Auto insurance quotes ... It is no longer necessary to call an agent or ... available online on a single website: http://autocarinsurancebest.com/ . , ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved television ... 32nd Annual Miami Breast Cancer Conference planned ... (PER®) , shares that “a fast-growing, virulent” cancer in ... had not followed up her clean mammogram with an ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... BASKING RIDGE, N.J., Nov. 9 Hooper Holmes,(Amex: ... its 50,000th participant,screening for health and wellness companies, ... to the screening of groups and,individuals, the gathering ... "This milestone, and the rapid rate at ...
... World Diabetes Day is,November 14, 2007 and Lifestyle ... of the 12-Day Stopping Diabetes Program series in ... 2 diabetes, this,program focuses on intensive lifestyle change ... Dr. Stuart Seale, medical director for the Stopping ...
... to limit heart-tissue damage during a heart attack will ... Paresh Dandona, M.D., Ph.D., University at Buffalo Distinguished Professor ... in the UB School of Medicine and Biomedical Sciences. ... U.S. and Latin America will be recruited to participate ...
... NEW YORK (Nov. 9, 2007) -- Hispanics in the ... population and have worse outcomes in some cases, according ... seek treatment only after developing more advanced disease. Reasons ... include a combination of socioeconomic factors and genetic variations. ...
... way of preventing deaths and severe complications arising from ... concludes research published ahead of print in Archives of ... and others likely to be at risk of contracting ... the UK. But vaccination programmes for children have been ...
... Britons has sex with a new partner while overseas, ... Sexually Transmitted Infections. , And they are apparently opting ... that this minimises the chances of HIV infection, but ... transmitted infections. , The findings are based on interviews ...
Cached Medicine News:Health News:Hooper Holmes Marks 50,000 Health and Wellness Screenings 2Health News:New Sedona Stopping Diabetes Program 2Health News:Landmark trial to evaluate cardioprotective properties of insulin 2Health News:New study questions disparities in vascular surgery among Hispanics 2Health News:Chicken pox vaccination should be introduced for children in the UK 2Health News:1 in 5 young Britons has sex with someone new while abroad 2
(Date:1/23/2015)... /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential ... ("Advaxis" or the "Company") (NASDAQ: ADXS ), ... to shareholders. On January 21, 2015, an ... Advaxis had misrepresented the clinical data for its ADXS-HPV ...
(Date:1/23/2015)... available for sale, The Armor1 Ankle Roll Guard is a ... by cushioning the ankle from an inversion or "roll." ... of any shoe type and allows the user to ... against sprains. With customers in physical therapy, podiatry, and ...
(Date:1/23/2015)... Jan. 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ... the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with ... and provides an update for shareholders detailing why a "YES" ... Dear Shareholders, As we reflect upon ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... Feb. 19 Joseph F. Finn, Jr.,CPA, the ... announced,today the design of a clinical trial to ... approved antibiotics. Rifalazil, the,most potent anti-chlamydial agent that ... treatment option for Chlamydia STD. The insidious aspect,of ...
... landscape of scientific,publications strategy, planning and delivery is ... global publications groups are fully,located in the marketing ... groups to increase clinical presentation, according to a ... a benchmarking study that included such influential companies ...
Cached Medicine Technology:ActivBiotics Outlines a Clinical Path Forward to Examine if Rifalazil Is Superior to Azithromycin in the Treatment of Chlamydia STD 2Industry Executives Finding Value in Shift of Scientific Publications 2
... is improved CNBT technology, which relieves the practitioner ... 15 minutes. HOPE allows you the ability to ... administration couldn't be easier, with a length of ... can turn the HOPE nebulizer into an inexpensive ...
... Thera-Mist® Air Entrainment Nebulizers deliver particulate ... range for your chronic secretion patients. For ... with your existing supply of sterile water., ... operates at FiO2's of 20-50% with a ...
Rotary Piston Mini Nebulizer...
Lumitex® LightMat® Surgical Illuminator improves visualization in deep cavity surgery. Flexible and malleable, it attaches easily to most retractors, bringing bright, cool area lighting where...
Medicine Products: